−0.36HKD
−747.48 MHKD
6.57 BHKD
1.08 B
About GENSCRIPT BIOTECH CORPORATION
Sector
Industry
CEO
Weihui Shao
Website
Headquarters
Nanjing
Employees (FY)
6.94 K
Founded
2002
ISIN
KYG3825B1059
FIGI
BBG009XY51J1
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1548 is 10.44 HKD — it has decreased by 8.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange GENSCRIPT BIOTECH CORPORATION stocks are traded under the ticker 1548.
GENSCRIPT BIOTECH CORPORATION is going to release the next earnings report on Aug 28, 2024. Keep track of upcoming events with our Earnings Calendar.
1548 stock is 10.83% volatile and has beta coefficient of 1.38. Check out the list of the most volatile stocks — is GENSCRIPT BIOTECH CORPORATION there?
One year price forecast for GENSCRIPT BIOTECH CORPORATION has a max estimate of 31.04 HKD and a min estimate of 23.02 HKD.
Yes, you can track GENSCRIPT BIOTECH CORPORATION financials in yearly and quarterly reports right on TradingView.
1548 stock has fallen by 17.41% compared to the previous week, the month change is a 32.90% fall, over the last year GENSCRIPT BIOTECH CORPORATION has showed a 55.19% decrease.
1548 net income for the last quarter is −14.83 M HKD, while the quarter before that showed −733.55 M HKD of net income which accounts for 97.98% change. Track more GENSCRIPT BIOTECH CORPORATION financial stats to get the full picture.
Today GENSCRIPT BIOTECH CORPORATION has the market capitalization of 24.23 B, it has decreased by 13.92% over the last week.
Like other stocks, 1548 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENSCRIPT BIOTECH CORPORATION stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 6.94 K employees. See our rating of the largest employees — is GENSCRIPT BIOTECH CORPORATION on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENSCRIPT BIOTECH CORPORATION technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENSCRIPT BIOTECH CORPORATION stock shows the strong sell signal. See more of GENSCRIPT BIOTECH CORPORATION technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on GENSCRIPT BIOTECH CORPORATION future price: according to them, 1548 price has a max estimate of 31.05 HKD and a min estimate of 23.02 HKD. Read a more detailed GENSCRIPT BIOTECH CORPORATION forecast: see what analysts think of GENSCRIPT BIOTECH CORPORATION and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENSCRIPT BIOTECH CORPORATION EBITDA is −2.47 B HKD, and current EBITDA margin is −37.65%. See more stats in GENSCRIPT BIOTECH CORPORATION financial statements.